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http://dx.doi.org/10.1016/j.pedneo.2
1875-9572/Copyright ª 2015, TaiwanCongenital brain tumors (CBTs), defined as tumors presenting within 60 days after birth, are
extremely rare and account for only 0.5e1.9% of all pediatric brain tumors. Teratoma is the
most common type of CBT, although there are many other poorly described forms. Prenatal
diagnosis of CBT is often difficult and usually based on clinical characteristics and radiological
findings with magnetic resonance imaging and ultrasonography. The prognosis of patients with
CBT depends on the histopathological features of the tumor and its location. Even after several
investigations have been performed, a clear direction for diagnosis and treatment of fetal
intracranial tumors is still lacking. Further studies are thus needed to clarify its clinical char-
acteristics and establish recommendations for management.
Copyright ª 2015, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Congenital brain tumor (CBT) is usually defined as a tumor
presenting within 60 days after birth.1,2 It is extremely rare
and accounts for only 0.5e1.5% of all pediatric brainardiology, Saitama Medical
981 Kamoda, Kawagoe, Sai-
-med.ac.jp (H. Senzaki).
015.04.004
Pediatric Association. Published btumors. The incidence of CBT ranges from approximately
0.3 cases per 100,000 live births in Japan to 2.9 cases per
100,000 live births in eastern Denmark.3,4 The incidence of
CBT has increased during the past 20 years, partly because
of improved diagnosis through recent advancements in
fetal ultrasonography.5,6 However, a clear guide for making
clinical decisions in perinatal patients is limited.7,8 In this
review, the available data on CBTdwith a special focus on
classification, diagnosis, prognosis, and managementdis
summarized with the hope of improving current knowledge
of the pathology and providing future directions for this
challenging condition.y Elsevier Taiwan LLC. All rights reserved.
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Congenital brain tumors are classified primarily by their
histological type (Table 1). Tumors diagnosed within 1 year
of birth are usually congenital in origin. However, brain
tumors diagnosed within 60 days after birth are distinct in
histological and clinical characteristics from tumors
appearing in the first 1e2 years of life. From an embryo-
logical point of view, it is interesting that most brain tumors
in infants are derived from gliomas (63%) such as astrocy-
tomas (36%),9,10 whereas a teratoma, a type of germ cell
tumor, is the most common type of CBT in fetuses and ne-
onates and accounts for approximately 30% of all CBTs
detected during the fetal and neonatal periods. The for-
mation of brain tumors during fetal and neonatal life may
begin at the time of normal brain cell differentiation. In
particular, germ cell tumors, which frequently occur before
32 weeks of gestation, contain cells that resemble cellsTable 1 Characteristics of perinatal and infant brain tumors.
Fetuses and neonates
Signs and symptoms Macrocephaly
Mass detected on prenatal ultrasonograph
Hydrocephalus
Stillbirth
Location of the tumor Supratentorial or infratentorial
Classification Intraparenchymal tumors
Representative
histological type
Germ cell tumor
e teratoma (30%)
Embryonal tumor
e medulloblastoma
e primitive neuroectodermal tumor (PENT
Glioma
e astrocytoma
e glioblastoma
Choroid plexus papilloma
Imaging findings of
ultrasonography
Heterogeneous pattern with the destructi
of normal structures
Teratoma (may have calcifications)
Choroid plexus papilloma
(appears as an overgrowth of the choroid
Treatment Intrauterine treatment
(e.g., transabdominal aspiration)
Surgery
Radiotherapy
Chemotherapy
Prognosis Extremely poor (except for choroid plexus
papilloma, pilocytic astrocytoma,
desmoplastic astrocytoma, & craniopharynthat are present during normal embryonic development
(Figure 1). This finding supports the hypothesis that these
tumors are derived from aberrant and residual cells during
the formation of the central nervous system. Therefore,
embryologic development of brain tumors diagnosed during
a prenatal examination may be different from those diag-
nosed after birth when the central nervous system is already
differentiated. There is a large variety of histopathological
types of CBTs such as astrocytomas, glioblastomas, choroid
plexus tumors, and primitive neuroectodermal tumors. The
proportion of each histopathological type, except for tera-
tomas, varies among different reports. However, this vari-
ability is likely because of the small number of patients in
these studies.1,4,5,10e12
Brain tumors can also be divided into two categories:
intraparenchymal tumors and extraparenchymal tumors.
Germ cell tumors belong to the former type. Intra-
parenchymal tumors invade the normal brain parenchymaInfants
y
Macrocephaly
Irritability
Seizure
Somnolence
Vomiting
Abnormal eye movements
Supratentorial or
infratentorial
Extraparenchymal
tumors
Intraparenchymal tumors
)
Lipomas
Hemangioma
Glioma (63%)
e astrocytoma (36%)
Choroid plexus papilloma
Embryonal tumor
e medulloblastoma
on
plexus)
Homogeneous
Lipomas
(appear hyperechogenic)
Surgery Surgery
Radiotherapy
Chemotherapy
gioma)
Comparatively favorable Poor
Figure 1 MassoneNoguchi staining of an intracranial tumor
(magnification, 20) shows differentiation into (A) the pul-
monary structure and (B) the medullary neural plates. The
details of this patient have been reported previously.44
Congenital Brain Tumor within 2 Months 371and are malignant, except for certain intraparenchymal
tumors such as choroid plexus papilloma, pilocytic astro-
cytoma, desmoplastic infantile astrocytoma, and cranio-
pharyngioma. By contrast, extraparenchymal tumors such
as lipoma and hemangioma are benign lesions (Table 1).3. Diagnosis
Biopsy and histopathological examination are essential for a
definitive diagnosis of a brain tumor,4,5 but it is virtually
impossible to obtain a fetal biopsy specimen safely.
Therefore, diagnosis must be determined on the basis of
imaging findings [ultrasonography (US) and magnetic reso-
nance imaging (MRI)], clinical features, and course of
disease.3,13,14 Congenital brain tumors tend to be supra-
tentorial, whereas brain tumors in older children tend to be
infratentorial. Most CBTs have a heterogeneous US pattern
with the destruction of normal structures (Figure 2). In
particular, teratomas are usually associated with calcifica-
tions, which may be important for diagnosis.15e17 Possible
exceptions to a heterogeneous US pattern are lipomas,Figure 2 Postnatal ultrasound images of a patient with a congen
plane image. Obstructive hydrocephalus (dotted arrows) and a he
presses against the left hemicerebrum, which has a normal structuwhich have a typical hyperechogenic homogeneous
appearance, and choroid plexus papillomas,11,18 which
appear as an overgrowth of the choroid plexus.18 In addi-
tion, CBTs are often associated with obstructive hydro-
cephalus that results from alterations in the flow of
cerebrospinal fluid (Figure 2). Fetal MRI is an emerging
technique that can provide valuable information for diag-
nosis and for management (Figure 3).7,19 Cranial ultraso-
nography and MRI are the mainstays of diagnostic
evaluation. Ultrasound images provide a noninvasive
approach for diagnosing CBT, and MRI provides comple-
mentary, detailed, and precise information.20 For example,
MRI occasionally reveals that a lesion is heterogeneous,
even if it appears homogeneous, and US indicates it is only
an unsuspected tumoral extension.11 MRI is also very useful
for localizing a lesion, which is important for treatment,
assessing complications, and neurological prognosis. How-
ever, because of the size of most tumors, it is often
impossible to locate the exact origin of the tumor.21
Gestational age of the patient may also provide useful
information about a diagnosis. Histological studies have
indicated that before 22 weeks the tumor is often a tera-
toma or a hamartoma. Germinal tumors are observed be-
tween 22 weeks and 32 weeks, and gliomas such as
astrocytomas and glioblastomas are detected after 32
weeks.22,23 On average, the gestational age at diagnosis is
27 weeks for teratomas, 21 weeks for hamartomas, and 34
weeks for gliomas.11 No information is available on the
relevant gestational age for the other types of CBTs.
Clinical presentations may also be helpful for the diag-
nosis of CBTs. The main features at presentation of intra-
cranial teratomas are macrocephaly, mass detected on
prenatal US, hydrocephalus, and stillbirth.5 Teratoma of
the brain may arise from the pineal gland and may involve
the third ventricle, which often results in hydrocephalus.
Teratomas may arise in the suprasellar and pineal regions
where they behave mostly as extra-axial tumors that
invaginate into the normal brain parenchyma.21 Further-
more, CBTs are occasionally accompanied by congenital
anomalies such as cleft lip or cleft palate and malforma-
tions of the heart and urinary tract.2,24,25 Anomalies asso-
ciated with CBTs most often occur in patients with
teratomas and craniopharyngiomas. Cleft palate/lip is
associated with teratomas, and low-set ears are associated
with craniopharyngiomas.24ital brain tumor. (A) The coronal plane image. (B) The sagittal
terogeneous echogenic mass lesion in the right hemicerebrum
re (solid arrows).
Figure 3 Magnetic resonance image of a fetal brain tumor detected during pregnancy. (A) A brain tumor and hydrocephalus in a
fetus at gestational age 25 weeks. (B) A brain tumor in the back of the head in a fetus at gestational age 26 weeks.
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Congenital brain tumors generally have a poor prognosis
with an overall survival of only 28% for fetuses and neo-
nates.5 This is related to several factors such as malignant
histological type, size and location of the tumor, immature
stage of fetal development, and treatment-related com-
plications.26 A CBTs with benign histological findings can
also be associated with a poor prognosis if it compresses the
brain stem and pons. Teratomas and primitive neuro-
ectodermal tumors are the most lethal tumors because they
are often located in deep areas such as the hemicerebrum
and corpus pineale; thus, these tumors cannot be surgically
removed and easily invade the brainstem. Radiotherapy
after surgery, even if the intervention is successful, usually
leads to developmental delay. However, Carstensen et al4
reported normal development in two patients with tera-
tomas after the complete removal of the tumor. In both
patients, the lesions were in the right orbit and far from the
brainstem, and thus suitable for surgery.
By contrast, choroid papillomas and astrocytomas have
comparatively favorable outcomes.1,5 These tumors are
pathologically benign and are derived from areas where
tumors do not usually directly or indirectly affect the
brainstem of neonates with an open anterior fontanel.
Pearl et al27 also documented a patient with benign hem-
angioma and good prognosis after the excision of the tumor.
Thus, a favorable prognosis is also possible in patients with
benign and extraparenchymal tumors, whereas prognosis is
extremely poor in patients with intraparenchymal tumors,
except for choroid plexus papillomas.4,28
5. Treatment
The principal treatment for CBT is surgery such as total or
partial resection and ventriculopleural shunt; however,intraoperativemortality during a total resection is high.29e32
The extent of the CBT and the general condition of the pa-
tient are important determinants of surgical outcome.33
Improvements in localization of lesions by brain imaging,
advances in pediatric neuroanesthesia and intensive care,
and the advent of microneurosurgical techniques have
markedly reduced intraoperative mortality of patient-
sdeven patients with large tumors.7 Adjuvant therapies are
not widely used in neonates. Radiation therapy is performed
in only 32% of neonatal patients because brain radiotherapy
generally results in severe intellectual and psychomotor
retardation.3,34 Chemotherapy is less commonly used.3,35,366. Timing of intervention and delivery
For treatment of patients with CBTs detected during fetal
development, deciding the appropriate timing of delivery is
very important because complications associated with
premature delivery may produce even more deleterious
outcomes than the tumor itself. By contrast, if delivery is
delayed until term, the associated hydrocephalus may
worsen the outcome. In addition, delayed delivery may
increase maternal risks such as dystocia and need for Ce-
sarean delivery with a larger incision because of the
enlarged fetal head.37,38 Several studies have investigated
when and how a neonate with CBT should be delivered, but
a definitive principle for management has yet to be ach-
ieved. Im et al28 reviewed the cases of 39 patients who
were prenatally diagnosed with intracranial teratoma, and
reported that delivery was necessary within 2 weeks after
the initial diagnosis in most patients, regardless of gesta-
tional age or type of teratoma. This highlights the under-
lying limitations in deciding the timing of delivery. By
contrast, Cavalheiro et al39 managed 18 patients with CBT
(5 patients with tumors of the choroid plexus and four pa-
tients with mature teratomas) and proposed an algorithm
•Wait as long as possible if 
hydrocephalus does not worsen.
•To take into account steroid 
administration to mother (<34 
weeks).
•Transabdominal aspiration, if 
there is hydrocephalus.
Imaging (Ultrasound, MRI)
+ Calcifications + Overgrowth of
the choroid plexus
s/o Teratoma s/o Choroid plexus 
papillomas
+ Hyperechogenic
s/o Lipoma
Hydrocephalus
Predicting poor prognosis.
Enough informed consent.
Heterogeneous pattern Homogeneous pattern
Preterm Term
Delivery
(-)
Wait to term period.
Surgery after birth
Congenital brain tumor
(+) Worsen
Figure 4 The proposed algorithm for the evaluation and management of congenital brain tumors. MRI, magnetic resonance
imaging; s/o, suspect of.
Congenital Brain Tumor within 2 Months 373for the treatment of CBT. Therapy with prenatal cortico-
steroids was associated with an overall reduction in
neonatal death, respiratory distress syndrome, cere-
broventricular hemorrhage, necrotizing enterocolitis, res-
piratory support, intensive care admissions, and systemic
infections during the first 48 hours following delivery.40
Furthermore, for fetuses < 34 weeks of gestational age,
the mother was treated with corticosteroids to accelerate
fetal lung maturation, and intrauterine decompression was
induced by repeated transabdominal aspiration for fetal
hydrocephalus while awaiting more favorable conditions for
delivery via Cesarean section.41 The outcomes were satis-
factory with the survival of 13 patients, which included
three patients with teratomas. However, transabdominal
aspiration may negatively affect prognosis because the
procedure may be complicated by the risk of intrauterine
infection, hemorrhage, and damage to the remaining ce-
rebral tissues.42,43 Furthermore, the size of the fetal head
may not be effectively reduced even after cephalocentesis
in a patient with a large CBT.38,42 Because of these aspects,
an algorithm for the evaluation and management CBT is
proposed in Figure 4.
There is an inherent limitation in deciding how and/or
whether to treat patients with CBTs. It is difficult to predictthe therapeutic effects and prognosis because of the chal-
lengesencountered in specifying theoriginand typeof tumor.
There is also a general lack of information regarding the
complete clinical picture of CBTs. For example, surgery is
effective in patients with lipomas, despite the large size of
the tumors. In addition, patients with intraparenchymal tu-
mors (e.g., teratomas, which were previously believed to be
malignant) have reportedly survived after surgery.39 Clini-
cians should provide detailed information to the family and
involve themin thedecision-makingprocess. It is important to
provide sufficient information to the family after multidisci-
plinary considerations from obstetricians, neonatologists,
neurosurgeons, and anesthesiologists, and to provide support
to the family to determine the course of treatment after the
diagnosis. Accurate prognostic information is generally diffi-
cult to obtain; therefore, health care providers and family
members should be flexible about modifying treatment,
depending on the postnatal circumstances.7. Conclusion
The available information regarding CBTs is limited. of the
pregnancy and perinatal treatment should be managed by
374 M. Sugimoto et alimaging studies and clinical features, as the proposed al-
gorithm shows. A nationwide collaborative study would be
helpful to clarify the complete clinical picture and to
establish a guide for the management of CBTs.
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